8:07 AM ET
8-K
Executive Compensation
Voyager Therapeutics Executive Compensation
Voyager Therapeutics appointed Robin Swartz as President and announced she will succeed Alfred W. Sandrock, Jr. as CEO in Q1 2027. In connection with the promotion, Swartz entered into an amended employment agreement providing for a $625,000 base salary, a 50% target bonus, and equity grants including 318,500 stock options and 68,250 restricted stock units.